Mark Kosinski, MA, Vice President and Senior Scientist at QualityMetric, recently authored an article for the May 2009 issue of Applied Clinical Trials. Focused on the importance of ensuring data accuracy during clinical trials, Kosinski highlights the steps you can take to avoid devastating data and scoring errors, and notes the potential impact these can have. He also comments on the availability of standardized scoring and data processing software that can be used to prevent errors, as well as what to consider when choosing the right software option for your needs.
Kosinski has co-authored over 120 peer-reviewed journal articles related to the development and analysis of patient-reported outcome (PRO) measures, and has contributed to ten manuals and interpretation guides for various PRO measures, including the SF-36®, SF-12®, and SF-8™ Health Surveys. Over the past ten years, he has been actively involved in working with the pharmaceutical industry in the analysis of clinical trial data with PRO measures as secondary indicators of treatment efficacy.